4th Quarter - Report

HOLLAND & KNIGHT LLP for ALLIANCE FOR REGENERATIVE MEDICINE

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocate for creation of national strategy for regenerative medicine. Advocate for new/modified regulations regarding FDA approval of regenerative medicine products. Lobbied in support of HR 1862, The Regenerative Medicine Promotion Act of 2011. Lobbied for FDA and NIH appropriation increase to prevent sequestration of funds.

LobbyistCovered position, as disclosed
LINDSAY BRITT —
MICHAEL WERNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1862 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.